Which group of asthma symptoms is prevented by leukotriene receptor antagonists?

Leukotriene receptor antagonists are a class of medication that help in managing asthma by blocking the action of leukotrienes, which are inflammatory chemicals in the body. These medications are particularly effective at reducing inflammation in the airways, decreasing mucus production, and preventing airway constriction. As a result, they play a crucial role in preventing asthma attacks in both adults and children.

Asthma attacks are characterized by sudden worsening of symptoms such as wheezing, shortness of breath, chest tightness, and coughing. By mitigating these inflammatory responses, leukotriene receptor antagonists can help maintain better breathing and reduce the frequency of such attacks, contributing to overall asthma management.

In contrast, other options may involve different mechanisms or treatments that target seasonal or year-round allergy symptoms, rather than focusing specifically on the prevention of asthma attacks.